Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
WAVE Life Sciences Ltd. (WVE) had Stock-Based Compensation of $24.97M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$17.25M |
|
$-53.18M |
|
-- |
|
$17.25M |
|
$73.71M |
|
$-56.47M |
|
$3.29M |
|
$-53.18M |
|
$-53.18M |
|
$-53.18M |
|
$-53.18M |
|
$-53.18M |
|
$-53.18M |
|
$-56.47M |
|
$-54.20M |
|
168.65M |
|
168.65M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$614.81M |
|
$7.41M |
|
$23.68M |
|
$638.50M |
|
$95.06M |
|
-- |
|
$25.08M |
|
$120.14M |
|
$518.36M |
|
$518.36M |
|
$518.36M |
|
187.66M |
|
| Cash Flow Statement Financials | |
$-187.49M |
|
$-0.72M |
|
$488.24M |
|
$305.84M |
|
$605.87M |
|
$300.04M |
|
|
Stock-Based Compensation |
$24.97M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-327.44% |
|
-327.44% |
|
-- |
|
-308.37% |
|
-308.37% |
|
$-188.21M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
13.51 |
|
6.66 |
|
-10.26% |
|
-10.26% |
|
-8.33% |
|
-10.26% |
|
$2.76 |
|
$-1.12 |
|
$-1.11 |
|